Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

Acute myeloid leukemia (AML) is characterized by arrested differentiation making differentiation therapy a promising treatment strategy. Recent success of inhibitors of mutated isocitrate dehydrogenase (IDH) invigorated interest in differentiation therapy of AML so that several new drugs have been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomic, Barbara, Smoljo, Tomislav, Lalic, Hrvoje, Dembitz, Vilma, Batinic, Josip, Batinic, Drago, Bedalov, Antonio, Visnjic, Dora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256737/
https://www.ncbi.nlm.nih.gov/pubmed/35790845
http://dx.doi.org/10.1038/s41598-022-15520-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256737/
https://www.ncbi.nlm.nih.gov/pubmed/35790845
http://dx.doi.org/10.1038/s41598-022-15520-z

Ejemplares similares